Objective To explore the possible effect of C-X-C motif
chemokine ligands13 (CXCL13) on the autophagy and proliferation of human mesenchymal stem cells (hBMSCs) and the underlying mechanisms. Methods The hBMSCs were divided into control group,
hypoxia group, CXCL13 treatment group, and CXCL13 combined with
SB203580 group. Except the control group, the rest of cells were cultured under the established
hypoxia condition of 920 mL/L N2, 30 mL/L O2 and 50 mL/L CO2. The cells of CXCL13 treatment group were stimulated with 50 ng/mL recombinant CXCL13. In the combination group, the cells were preincubated with 20 μmol /L of MAPK inhibitor
SB203580 for 30 minutes and subsequently treated with 50 ng/mL recombinant CXCL13. MTT assay was used to determine the proliferation of hBMSCs. The apoptosis rate of hBMSCs was analyzed by
annexin V-FITC/PI double labeling and flow cytometry. The
protein levels of nuclear factor-κB (NF-κB) and
beclin-1 were measured by Western blot analysis. ELISA was used to measure the content of
autophagy-related protein 7 (ATG7) in cell lysis
buffer. Results Compared with the
hypoxia group and the combination group. The cell proliferation,
beclin-1 and NF-κB
protein levels increased significantly in the CXCL13 treatment group however, the apoptosis rate decreased, and the level of ATG7 increased significantly in cell lysate. Conclusion Under hypoxic condition, CXCL13 promotes autophagy and proliferation of hBMSCs through the MAPK/NF-κB signaling pathway.